178 related articles for article (PubMed ID: 33789556)
1.
Maya-Barrios A; Lira-Hernandez K; Jiménez-Escobar I; Hernández L; Ortiz-Hernandez A; Jiménez-Gutiérrez C; López-Velázquez G; Gutiérrez-Castrellón P
Benef Microbes; 2021 Apr; 12(2):137-145. PubMed ID: 33789556
[TBL] [Abstract][Full Text] [Related]
2. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study.
Francavilla R; Lionetti E; Castellaneta S; Ciruzzi F; Indrio F; Masciale A; Fontana C; La Rosa MM; Cavallo L; Francavilla A
Aliment Pharmacol Ther; 2012 Aug; 36(4):363-9. PubMed ID: 22680836
[TBL] [Abstract][Full Text] [Related]
3. Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659.
Sendelius M; Axelsson J; Liu P; Roos S
J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37974056
[TBL] [Abstract][Full Text] [Related]
4. Evaluation on immediate analgesic efficacy and safety of Kai-Hou-Jian spray (children's type) in treating sore throat caused by acute pharyngitis and tonsillitis in children: study protocol for a randomized controlled trial.
Ma YN; Zhong CL; Hu SY; Cai QH; Guo SX
Trials; 2021 Mar; 22(1):216. PubMed ID: 33736674
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri influences regrowth of mutans streptococci after full-mouth disinfection: a double-blind, randomised controlled trial.
Romani Vestman N; Hasslöf P; Keller MK; Granström E; Roos S; Twetman S; Stecksén-Blicks C
Caries Res; 2013; 47(4):338-45. PubMed ID: 23486236
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children.
Szajewska H; Urbańska M; Chmielewska A; Weizman Z; Shamir R
Benef Microbes; 2014 Sep; 5(3):285-93. PubMed ID: 24463209
[TBL] [Abstract][Full Text] [Related]
7. A novel delivery system of probiotic drop and its effect on dental caries risk factors in cleft lip/palate children.
Cildir SK; Sandalli N; Nazli S; Alp F; Caglar E
Cleft Palate Craniofac J; 2012 May; 49(3):369-72. PubMed ID: 21309653
[TBL] [Abstract][Full Text] [Related]
8. Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients.
Alforaidi S; Bresin A; Almosa N; Lehrkinder A; Lingström P
BMC Microbiol; 2021 Oct; 21(1):271. PubMed ID: 34615458
[TBL] [Abstract][Full Text] [Related]
9. Heat-killed Limosilactobacillus reuteri ATCC PTA 6475 prevents bone loss in ovariectomized mice: A preliminary study.
Ribeiro JL; Santos TA; Garcia MT; Carvalho BFDC; Esteves JECS; Moraes RM; Anbinder AL
PLoS One; 2024; 19(5):e0304358. PubMed ID: 38820403
[TBL] [Abstract][Full Text] [Related]
10. In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications.
Gangaiah D; Mane SP; Tawari NR; Lakshmanan N; Ryan V; Volland A; Susanti D; Patel M; Abouzeid A; Helmes EB; Kumar A
PLoS One; 2022; 17(1):e0262663. PubMed ID: 35081129
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
Jørgensen MR; Keller MK; Kragelund C; Hamberg K; Ericson D; Nielsen CH; Twetman S
Acta Odontol Scand; 2016 Jul; 74(5):399-404. PubMed ID: 27104984
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis.
Gupta N; Ferreira J; Hong CHL; Tan KS
Sci Rep; 2020 Oct; 10(1):16189. PubMed ID: 33004948
[TBL] [Abstract][Full Text] [Related]
13. Lack of Efficacy of Lactobacillus reuteri DSM 17938 for the Treatment of Acute Gastroenteritis: A Randomized Controlled Trial.
Szymański H; Szajewska H
Pediatr Infect Dis J; 2019 Oct; 38(10):e237-e242. PubMed ID: 31033909
[TBL] [Abstract][Full Text] [Related]
14. Presence of Lactobacillus reuteri in saliva coincide with higher salivary IgA in young adults after intake of probiotic lozenges.
Braathen G; Ingildsen V; Twetman S; Ericson D; Jørgensen MR
Benef Microbes; 2017 Feb; 8(1):17-22. PubMed ID: 27873545
[TBL] [Abstract][Full Text] [Related]
15. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
Iniesta M; Herrera D; Montero E; Zurbriggen M; Matos AR; Marín MJ; Sánchez-Beltrán MC; Llama-Palacio A; Sanz M
J Clin Periodontol; 2012 Aug; 39(8):736-44. PubMed ID: 22694350
[TBL] [Abstract][Full Text] [Related]
16. Safety of Lactobacillus Reuteri DSM 17938 in Healthy Children 2-5 Years of Age.
Kosek MN; Peñataro-Yori P; Paredes-Olortegui M; Lefante J; Ramal-Asayag C; Zamora-Babilonia M; Meza-Sanchez G; Oberhelman RA
Pediatr Infect Dis J; 2019 Aug; 38(8):e178-e180. PubMed ID: 30531312
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938.
Savino F; Ceratto S; Poggi E; Cartosio ME; Cordero di Montezemolo L; Giannattasio A
Benef Microbes; 2015; 6(3):245-51. PubMed ID: 25488262
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting.
Dinleyici EC; Dalgic N; Guven S; Metin O; Yasa O; Kurugol Z; Turel O; Tanir G; Yazar AS; Arica V; Sancar M; Karbuz A; Eren M; Ozen M; Kara A; Vandenplas Y
J Pediatr (Rio J); 2015; 91(4):392-6. PubMed ID: 25986615
[TBL] [Abstract][Full Text] [Related]
19.
García Contreras AA; Vásquez Garibay EM; Sánchez Ramírez CA; Fafutis Morris M; Delgado Rizo V
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998471
[TBL] [Abstract][Full Text] [Related]
20. Effects of
Wälivaara DÅ; Sjögren I; Gerasimcik N; Yucel-Lindberg T; Twetman S; Abrahamsson P
Benef Microbes; 2019 Jul; 10(6):653-659. PubMed ID: 31157556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
